Thousand Oaks, CA-August 5, 2009 Integrated Clinical Solutions (Inclinical) a developer of collaborative clinical operations software for the pharmaceutical, biotechnology and medical device industries, has partnered with Terrosa Technologies (Terrosa) to be its exclusive worldwide sales and distribution agent.
Inclinical and Terrosa have teamed up to bring inclinicalperform, to the clinical trial industry using Software as a Service (SaaS) technology. Terrosa will have exclusive responsibility for the sales of inclinicalperform software as well as developing the go-to-market strategies and sales operations.
Inclinical's, inclinicalperform, provides a collaborative working environment for clinical operations teams comprised of Sponsors, CROs, Sites and other stakeholders. Inclinicalperform provides all the basic functionality of traditional Clinical Trial Management Systems (CTMS) and integrates those functions with collaborative document control and distribution, issue/query resolution and contact resource management. Inclinicalperform is designed to support Title 21 CFR, Part 11, FDA compliance and good Information security practices.
"We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development of new process automations within inclinicalperform," said Kim Terry, President of Terrosa Technologies. Armerding also stated, "Terrosa's integrated services will allow us to stay focused on what we do best-automating the clinical operations process."
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.